Summary
Molbio Diagnostics' share price fell 9% today, marking an 18.5% loss in two days due to profit booking, despite the stock remaining over 50% above its IPO price after a recent rally.
Molbio Diagnostics Share Price Falls 9%, Loses 18.5% in 2 Days After Rally
HyperFast News
Related news
Molbio Diagnostics Share Price Hits 20% Upper Circuit, Jumps 87% from IPO Price
19 Sept 2026, 1:58 pm · News
Molbio Diagnostics Outlines Global Expansion and Truenat Growth Plans After Successful IPO
19 Sept 2026, 1:58 pm · News
Molbio Diagnostics IPO Shares Debut at 21% Premium Amid Weak Market
19 Sept 2026, 1:58 pm · News
